Fox Business - The Power to Prosper
Search Site

Drug Companies

How much of a threat does Ebola pose to U.S.?

NYU Langone Medical Center’s Dr. Natalie Azar on the Ebola outbreak in Africa.

Read More

  1. Stossel 03/27/14: Government bullies

    Stossel and guest discuss how government uses its force to push people around and take their stuff

  2. Study reveals antibiotic-resistant Superbug found in homes

    FNC Medical A-Team’s Dr. Marc Siegel on the MRSA Superbug, Ebola and a second wave of the Flu hitting the Northeastern U.S.

  3. What to expect from pharma

    Robert W. Baird & Co. senior analyst Brian Skorney on what investors can expect from pharma in the second quarter.

  4. Pharma Deal Frenzy: A Bid to Boost Profits

    High-priced pharmacy deals are all the rage this year as big drug companies stung by patent expirations attempt to offset losses and reduce risk and costs by joining...

  5. Valeant won't pay whatever it takes for Allergan: CEO

    Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Mi...

  6. Novartis Announces Multi-Billion-Dollar Revamp

    Novartis (NYSE:NVS) is revamping its portfolio with a flurry of deals worth about $25 billion, as the Swiss pharmaceutical giant plans to swap assets with GlaxoSmith...

  7. Market check: AZN, PFE, GM

    FBN’s Lauren Simonetti with the latest on the market.

  8. $101B AstraZeneca deal happening?

    Strategas Research Partners CIO Jason Trennert and Philadelphia Trust Company CEO Michael Crofton on the M&A market for pharmaceutical and biotech companies.

  9. David, Goliath Team Up to Cure Rare Diseases

    In the world of drug development, collaboration is key.When Kathy Giusti was diagnosed with a rare and fatal blood cancer nearly 20 years ago, there wasn't a single ...

  10. What’s next for biotech?

    Acorda Therapeutics CEO Ron Cohen gives insider perspective on his company’s success and the recent biotech selloff.

  11. GSK Faces Criminal Bribery Investigation In Poland

    GlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors to promote its lung drug Seretide, adding to problems for a company alread...

  12. Top institutions squeezed by rising health-care costs

    Mayo Clinic CEO Dr. John Noseworthy and American Action Forum president Douglas Holtz-Eakin discuss health-care spending.

  1. Global cyber-crime market sized at $104B

    F5 Networks CEO John McAdam explains why company shares are continuing to rise and how the company protects data.

  2. DOJ charges FedEx in prescription drug shipping probe

    Former federal prosecutor Doug Burns on the DOJ’s indictment of FedEx over prescription drug shipments.

  3. Ralph Nader: It’s an institutional cover-up

    ‘Unstoppable’ author Ralph Nader on the mounting General Motors recall scandal.

  4. 14 tech, drug companies parking cash overseas

    FBN’s Liz MacDonald on companies with massive overseas cash piles.

  5. More states ready to approve ‘Right to Try’ bill?

    The Goldwater Institute’s Lucy Caldwell on the ‘Right to Try’ legislation.

  6. Omnicom-Publicis deal collapse: What’s next?

    MDC Partners CEO Miles Nadal on the collapse of the Omnicom-Publicis deal.

  7. Looking at LinkedIn

    Schaefer’s Investment Research senior equity analyst Joe Bell and Bryn Mawr Trust CIO Ernie Cecilia on LinkedIn and other stocks to invest in.

‹ Prev12345Next ›
Freebase CC-BY
Source: Drug Companies on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL